Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Kathryn Wood, Emeritus Professor of Immunology at Oxford University’s Nuffield Department of Surgical Sciences, recently received the 2017 Thomas E. Starzl Prize in Surgery and Immunology in recognition of her outstanding basic scientific and clinical research achievements.

Professor Kathryn Wood receiving the award from Dr Fadi Lakkis (Frank & Athena Sarris Chair in Transplantation Biology and Scientific Director of the Thomas E. Starzl Transplantation Institute)

The University of Pittsburgh School of Medicine, the Department of Surgery and the Thomas E. Starzl Transplantation Institute award the prize annually to a national or international leader in the field of organ transplantation and immunology.

Professor Kathryn WoodProfessor Wood has led the Transplantation Research Immunology Group (TRIG) – formerly called the Wood lab at NDS since 1982 and has made huge contributions to the fields of immunology and transplantation. Her research focuses on immune responses that lead to transplant rejection and immune regulation as a strategy to achieve immunological tolerance. In 2005, Kathryn showed that regulatory T cells (Treg) generated by controlled exposure to donor antigens prevented allograft rejection. She has played a key leadership role in the EU funded consortium project - The ONE Study -  that has enabled the initial testing of Treg therapy in clinical organ transplantation. Her research has also contributed to the development of a cross-platform biomarker signature to detect renal transplant tolerance in patients with the aim of achieving minimal immunosuppression.

Professor Wood visited the University of Pittsburgh School of Medicine in October to formally receive the prize, which consisted of a crystal award and an honorarium of $10,000 (£7,531), and to present the Starzl Prize lecture, entitled ‘Immune Regulation in Transplantation – From Mechanisms to Cell Therapy’.

Read more about the Thomas E. Starzl Prize in Surgery and Immunology and Professor Kathryn Wood.

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.